期刊文献+

高敏感C反应蛋白与急性冠脉综合征患者冠状动脉病变程度的关系

原文传递
导出
摘要 目的:评价高敏感C反应蛋白与冠状动脉病变严重程度的相关性,为临床诊疗提供依据。方法:对入选者进行冠状动脉造影,根据造影结果将入选者分为四组,用Gensini积分方法对冠状动脉病变程度进行积分,采用免疫速率散射比浊法测定各组血浆中高敏感C-反应蛋白(hs-CRP)含量,研究hs-CRP与冠状动脉病变程度的关系。结果:与对照组相比,单支病变组、双支病变组及三支病变组,血浆hs-CRP显著增加。结论:hs-CRP与冠状动脉造影病变程度一致,检测hs-CRP可预测冠状动脉病变的严重程度。
出处 《中国误诊学杂志》 CAS 2010年第7期1551-1552,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

  • 1Tataru MC, Hcinrich J,Jnuker R,et al. Creactive protein and the severity of arteriosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J, 2000,21 (12) 1000-1008.
  • 2Palmerini T, Marzocchi A, Marrozzin C, et al. Preprocedura levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis [J ]. Circulation, 2005,112 (3) 2332-2338.
  • 3赵翠花,程冠昌,万琪琳,何瑞利.阿托伐他汀对急性心肌梗死患者内皮功能和斑块稳定性的影响[J].临床心血管病杂志,2006,22(4):200-202. 被引量:32

二级参考文献13

  • 1熊全庚,范木林,郭跃华.早期强化辛伐他汀治疗急性冠状动脉综合征的研究[J].临床心血管病杂志,2004,20(12):710-712. 被引量:25
  • 2KINLAY S, SELWYN A P, DELAGRANGE D, et al. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use ofsurrogate end points [J]. Curr Opin Lipidol, 1996,7:389-397.
  • 3ALBEROLA AGUILAR A M, REVERT F, MOYA A, et al. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion[J]. Gen Pharmacol, 2000, 35 : 143- 147.
  • 4TRACY R P, LEMSITRE R N, PSATY B M, et al.Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the real health promotion project [J]. Arterioscler Thromb Vase Biol, 1997,17:1121-1126.
  • 5WATERS D D, AZAR R R. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes [J]. Am J Cardiol, 2000, 86(8B): 35J-42J.
  • 6LIUZZO G, BIASUCCI L M, GALLIMORE J R, et al. The prognostic value of C-reactive protein and serum amyloid- A ptrotein in severe unstable angina [J].N Engl J Med, 1994, 331:417-424.
  • 7IGARASSHI M, TAKEDA Y, ISHIBASHI N, et al.Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYW6228,and its inhibitory effect on vascular smooth muscle cell growth[J]. Br J Pharmacs, 1997, 120:1172-1178.
  • 8KURIHARA H, YOSHIZUMI M, SUGIYAMA T,et al . The possible role of endothelin-1 in the pathogenesis of coronary vasospasm [J]. J Cardiovasc Pharmacol. 1989, 13(Suppl 5): S132-137.
  • 9LEA A P, McTAVISH D. Atorvastatin. a review of its pharmacolog and therapeutic potential in the management of hyperlipidemias [J]. Drugs, 1997, 53:828-847.
  • 10DIOMEDE L, ALBANI D, SOTTOCOMO M, et al.In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products[J]. Arterioscler Thromb Vasc Biol, 2001, 21:1327-1332.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部